Who we are
The ANZCHOG Biobanking Network was established in 2017 to promote and improve the biobanking of childhood and adolescent/ young adult cancer samples at hospitals, research institutes, and Universities in Australia and New Zealand. The network is comprised of all 9 existing paediatric and adolescent/young adult cancer biobanks across Australia and New Zealand.
Thousands of samples/ biospecimens are available across the network, and access can be requested here.
Why a biobanking network?
Clinical samples, such as tissue and blood, are collected from patients during procedures for diagnosis and treatment. The portions of these biospecimens that are not used for diagnosis (and their associated clinical data), can be stored in biobanks for many years – they are invaluable sources of material for biomedical research. As childhood cancers are rare, the numbers of biospecimens collected and stored by individual biobanks are limited to the number of patients associated with that biobank. A biobanking network however, allows the use of large cohorts of biospecimens that are collected and stored by multiple biobanks (using similar procedures), that are required for large collaborative translational studies. A biobanking network will ensure that the increasing demands for high quality biospecimens needed to improve translational cancer research can be met, particularly with the shift towards personalised medicine to treat childhood cancer.
ANZCHOG Biobanking Network’s mission is to accelerate progress in research and treatment outcomes for children and adolescents / young adults with cancer, through cooperative best biobanking practices.
ANZCHOG Biobanking Network aims to improve research quality and patient care by:
- Promoting best-practice biobanking within the network, through harmonisation of standard operating procedures for the acquisition, handling, storage, and distribution of high quality biospecimens for research.
- Ensuring that biospecimens are used in a fair, ethical, and sustainable manner.
- Improving quality and standardisation of clinical data.
- Enhancing opportunities for national and international research collaborations.
The ANZCHOG Biobanking Network is governed by a network/ steering committee for decisions around biospecimen distribution, and reports to the ANZCHOG Executive Council.
The ANZCHOG Biobanking Network is a subgroup of the Australia and New Zealand Children’s Haematology / Oncology Group.
Network members are biobanks that collect and store samples from children and adolescent/young adults in Australia and New Zealand.
The Guardian, 8 May 2015Scientists have created the world’s first “living biobank” of patients’ tumours and used the tissue to identify the most promising drugs for each person’s disease